- Home
- CHGG vs PLRX Comparison
CHGG vs PLRX Comparison
Compare CHGG & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHGG
- PLRX
- Stock Information
- Founded
- CHGG 2005
- PLRX 2015
- Country
- CHGG United States
- PLRX United States
- Employees
- CHGG N/A
- PLRX N/A
- Industry
- CHGG Other Consumer Services
- PLRX Biotechnology: Pharmaceutical Preparations
- Sector
- CHGG Real Estate
- PLRX Health Care
- Exchange
- CHGG Nasdaq
- PLRX Nasdaq
- Market Cap
- CHGG 154.4M
- PLRX 165.5M
- IPO Year
- CHGG 2013
- PLRX 2020
- Fundamental
- Price
- CHGG $1.43
- PLRX $3.08
- Analyst Decision
- CHGG Hold
- PLRX Buy
- Analyst Count
- CHGG 8
- PLRX 10
- Target Price
- CHGG $3.14
- PLRX $14.86
- AVG Volume (30 Days)
- CHGG 2.4M
- PLRX 3.4M
- Earning Date
- CHGG 02-24-2025
- PLRX 03-07-2025
- Dividend Yield
- CHGG N/A
- PLRX N/A
- EPS Growth
- CHGG N/A
- PLRX N/A
- EPS
- CHGG N/A
- PLRX N/A
- Revenue
- CHGG $662,077,000.00
- PLRX N/A
- Revenue This Year
- CHGG N/A
- PLRX N/A
- Revenue Next Year
- CHGG N/A
- PLRX N/A
- P/E Ratio
- CHGG N/A
- PLRX N/A
- Revenue Growth
- CHGG N/A
- PLRX N/A
- 52 Week Low
- CHGG $1.30
- PLRX $2.43
- 52 Week High
- CHGG $9.14
- PLRX $18.00
- Technical
- Relative Strength Index (RSI)
- CHGG 43.66
- PLRX 22.51
- Support Level
- CHGG $1.30
- PLRX $2.92
- Resistance Level
- CHGG $1.58
- PLRX $3.16
- Average True Range (ATR)
- CHGG 0.11
- PLRX 0.85
- MACD
- CHGG 0.01
- PLRX -0.39
- Stochastic Oscillator
- CHGG 34.21
- PLRX 6.22
About CHGG Chegg Inc.
Chegg Inc is an American educational services company. The Chegg platform provides products and services to support learners with their academic course materials, as well as their career and personal skills development. The company's service and product offerings fall into two categories: Subscription Services, which encompasses Chegg Study Pack, Chegg Study, Chegg Writing, Chegg Math, and Busuu offerings that can be accessed internationally through the company's websites and on mobile devices, and Skills and Other, which encompasses skills, advertising services, print textbooks, and eTextbooks offerings.
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.